The largest database of trusted experimental protocols

Recombinant human egf

Manufactured by Cell Signaling Technology
Sourced in United States

Recombinant human EGF is a protein produced in E. coli cells. It is a growth factor that binds to the epidermal growth factor receptor (EGFR) and stimulates cell proliferation.

Automatically generated - may contain errors

5 protocols using recombinant human egf

1

Antibody Staining Techniques for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following primary antibodies were used: rabbit anti-HB-EGF (antibodies-online), mouse anti-Myc (9B11; Cell Signaling Technologies), rabbit anti-EGF (antibodies-online), rabbit antipro-EGF (against aa 700-800; Novus Biologicals, R&D Systems Europe Ltd, England), rabbit anti-APP C-Terminal (clone CT695; Invitrogen), mouse anti-APP N-terminal (clone 22C11; Chemicon), mouse anti-APP residues 1-16 of Abeta (clone 6E10), rabbit anti-ERK1/2 (Millipore, Merck Life Science S.L.U., Portugal), rabbit anti-phosphorylated ERK1/2 (Thr202/Tyr204 Erk1 and Thr185/Tyr187 Erk2; Millipore), anti-acetylated alpha-tubulin (Sigma-Aldrich, Química S.A., Portugal), mouse anti-βIII Tubulin (Sigma-Aldrich). HRPconjugated anti-mouse and anti-rabbit secondary antibodies were from GE-Healthcare.
Secondary antibodies Alexa Fluor 405 goat anti-rabbit, Alexa Fluor 594 goat anti-rabbit or anti-mouse, and Alexa Fluor 488 goat anti-mouse were from Life Technologies. Human recombinant EGF was from Cell Signaling and was used at a 100 ng/mL working concentration (WC). The EGFR inhibitor drug PD 168393 (Sigma-Aldrich) was used at 10 µM WC. Texas Red-conjugated Transferrin was from Molecular Probes.
+ Open protocol
+ Expand
2

Antibody Staining Techniques for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following primary antibodies were used: rabbit anti-HB-EGF (antibodies-online), mouse anti-Myc (9B11; Cell Signaling Technologies), rabbit anti-EGF (antibodies-online), rabbit antipro-EGF (against aa 700-800; Novus Biologicals, R&D Systems Europe Ltd, England), rabbit anti-APP C-Terminal (clone CT695; Invitrogen), mouse anti-APP N-terminal (clone 22C11; Chemicon), mouse anti-APP residues 1-16 of Abeta (clone 6E10), rabbit anti-ERK1/2 (Millipore, Merck Life Science S.L.U., Portugal), rabbit anti-phosphorylated ERK1/2 (Thr202/Tyr204 Erk1 and Thr185/Tyr187 Erk2; Millipore), anti-acetylated alpha-tubulin (Sigma-Aldrich, Química S.A., Portugal), mouse anti-βIII Tubulin (Sigma-Aldrich). HRPconjugated anti-mouse and anti-rabbit secondary antibodies were from GE-Healthcare.
Secondary antibodies Alexa Fluor 405 goat anti-rabbit, Alexa Fluor 594 goat anti-rabbit or anti-mouse, and Alexa Fluor 488 goat anti-mouse were from Life Technologies. Human recombinant EGF was from Cell Signaling and was used at a 100 ng/mL working concentration (WC). The EGFR inhibitor drug PD 168393 (Sigma-Aldrich) was used at 10 µM WC. Texas Red-conjugated Transferrin was from Molecular Probes.
+ Open protocol
+ Expand
3

Spheroid Cultivation and Characterization of HCT-8 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT-8 cells (2.5 × 105 per well) were seeded in the ultralow attachment 6-well plates (Corning Incorporated, Corning, NY, USA). Spheroid cells were cultivated for 6 days in the spheroid culture media (DMEM containing B27 (Life Technology, Waltham, MA, USA)), 20 ng/ml of bFGF (PEPROTECH, Rocky Hill, NJ, USA), 20 ng/ml of recombinant human EGF (Cell Signaling), and 1% antibiotics. To verify the competence of colonospheres, 6-day cultured spheroids were fixed with 4% paraformaldehyde containing 1% triton X-100 at 4 °C overnight, then fixed with 4% paraformaldehyde over 2 h. Spheroids were washed with PBS, blocked with 3% BSA, and then incubated with mouse anti-human CD44 (1:200, Cell signaling) at 4 °C overnight. The fixed spheroids were subsequently washed in PBS, incubated with Cy3-conjugated goat anti-mouse IgG (Abcam, Cambridge, UK) for 2 h at room temperature, washed in PBS, and counterstained with 100 ng/ml DAPI (absorbance at 405 nm, Sigma-Aldrich) in PBS for 10 min. Spheroids were washing with PBS 5 times for 8 min each, observed, and analyzed under a confocal laser scanning microscope (FV1000, Olympus, Nagano, Japan). To compare sphere sizes, about 200 spheroids per group were randomly selected, after which their perimeters were measured and statistically analyzed.
+ Open protocol
+ Expand
4

Neurosphere Assay for Neural Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The neurosphere assay was modified from Deleyrolle and Reynolds (Deleyrolle and Reynolds, 2009 (link)). Whole E14.5 brains were dissected and mechanically dissociated until the suspension was homogenous. After centrifugation, the pellet was resuspended in an appropriate amount of neuronal proliferation medium containing neurobasal medium (Invitrogen), glutamine (Invitrogen), glutamax (Invitrogen), B27 (Invitrogen), 20 ng/μl recombinant human EGF (Cell Signaling), 20 ng/μl recombinant human basic FGF (Cell Signaling) and 5 μg/μl heparin (Sigma). After 4 days, cells were gently dissociated with 0.05% trypsin/EDTA (Invitrogen) and seeded for treatments. Twenty-four hours after seeding, neurospheres were treated for 48 hours either with 1 μM Rottlerin (Zhang et al., 2007 (link)) or as a negative control with the solvent dimethyl sulfoxide (DMSO) only. After treatment, cells were either pelleted and frozen for immunoblot analysis or plated for additional 24 hours on poly-L-lysine/laminin coated glass coverslips for microscopy.
+ Open protocol
+ Expand
5

Neurosphere Assay for Neural Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The neurosphere assay was modified from Deleyrolle and Reynolds (Deleyrolle and Reynolds, 2009 (link)). Whole E14.5 brains were dissected and mechanically dissociated until the suspension was homogenous. After centrifugation, the pellet was resuspended in an appropriate amount of neuronal proliferation medium containing neurobasal medium (Invitrogen), glutamine (Invitrogen), glutamax (Invitrogen), B27 (Invitrogen), 20 ng/μl recombinant human EGF (Cell Signaling), 20 ng/μl recombinant human basic FGF (Cell Signaling) and 5 μg/μl heparin (Sigma). After 4 days, cells were gently dissociated with 0.05% trypsin/EDTA (Invitrogen) and seeded for treatments. Twenty-four hours after seeding, neurospheres were treated for 48 hours either with 1 μM Rottlerin (Zhang et al., 2007 (link)) or as a negative control with the solvent dimethyl sulfoxide (DMSO) only. After treatment, cells were either pelleted and frozen for immunoblot analysis or plated for additional 24 hours on poly-L-lysine/laminin coated glass coverslips for microscopy.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!